Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease rheumatoid arthritis
Comorbidity C0024115|lung disease
Sentences 36
PubMedID- 20884744 The outcome and cause of death of each lung disease directly associated with rheumatoid arthritis (ra-ld) have been poorly investigated.
PubMedID- 25026811 [subclinical interstitial lung disease associated with rheumatoid arthritis].
PubMedID- 21325762 Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of pneumocystis pneumonia in japan revealed by a multicenter study.
PubMedID- 25665185 Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
PubMedID- 22806097 We also present a third clinical entity, that of lung disease associated with rheumatoid arthritis (rheumatoid lung), representing a condition that can manifest as either phenotype, and offering a potential opportunity to explore the mechanisms underlying the pathogenesis of the two distinct fibrotic phenotypes.
PubMedID- 23588941 Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis.
PubMedID- 22265461 Rheumatoid nodules are a rare manifestation of lung disease associated with rheumatoid arthritis (ra).
PubMedID- 20522855 A case of debilitating cavitating lung disease associated with rheumatoid arthritis and bronchocentric granulomatosis, which failed to respond to conventional medical or surgical treatment, is described.
PubMedID- 25746669 A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in chinese patients.
PubMedID- 20851924 However, mortality rates from rheumatoid arthritis-associated interstitial lung disease increased 28.3% in women (to 3.1 per million persons in 2004) and declined 12.5% in men (to 1.5 per million persons in 2004).
PubMedID- 22185348 A novel model of rheumatoid arthritis-associated interstitial lung disease in skg mice.
PubMedID- 23819345 [diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis].
PubMedID- 24378059 [effect of selective phosphodiesterase 4 inhibitors on nuclear factor kappa b, tumor necrosis factor-alpha and interleukin-8 expression in peripheral blood mononuclear cells in rheumatoid arthritis with interstitial lung disease].
PubMedID- 26090479 Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis.
PubMedID- 24757133 Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
PubMedID- 25125479 Potential risk of tnf inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
PubMedID- 26508946 However, these agents are widely prescribed for patients with ankylosing spondylitis, and case reports describe beneficial effects in patients with interstitial lung disease associated with rheumatoid arthritis.
PubMedID- 23899235 Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
PubMedID- 24570384 Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.
PubMedID- 24681841 Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: reply.
PubMedID- 24743261 Anti-cyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
PubMedID- 25744479 Backgrounds: interstitial lung disease (ild) is associated with rheumatoid arthritis (ra) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs.
PubMedID- 22239947 Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
PubMedID- 26075419 A guide to improving detection of interstitial lung disease in patients with rheumatoid arthritis.
PubMedID- 24681838 Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
PubMedID- 24626274 Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis.
PubMedID- 25589842 rheumatoid arthritis-associated interstitial lung disease (ra-ild), the most common manifestation of rheumatoid lung disease [1], occurs more frequently in patients with severe ra.
PubMedID- 25836639 lung disease in rheumatoid arthritis.
PubMedID- 24909129 Methotrexate and lung disease in rheumatoid arthritis: comment on the article by conway et al.
PubMedID- 22341526 Objective: to describe the evolution of lung function in a cohort of rheumatoid arthritis (ra) patients with interstitial lung disease (ild) treated according to the medical judgment of attending physicians.
PubMedID- 22084614 We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside.
PubMedID- 26401101 Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis.
PubMedID- 25922727 Changes in peripheral cd19(+)foxp3(+) and cd19(+)tgfbeta(+) regulatory b cell populations in rheumatoid arthritis patients with interstitial lung disease.
PubMedID- 23661426 A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
PubMedID- 20480164 A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.
PubMedID- 24521636 Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study.

Page: 1